APA (7th ed.) Citation

BG, B., T, D., S, P., BS, P., S, S., & B, B. (2023). Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system. Acta psychiatrica Scandinavica, 148(1), 32. https://doi.org/10.1111/acps.13567

Chicago Style (17th ed.) Citation

BG, Burk, DiGiacomo T, Polancich S, Pruett BS, Sivaraman S, and Birur B. "Antipsychotics and Obsessive-compulsive Disorder/obsessive-compulsive Symptoms: A Pharmacovigilance Study of the FDA Adverse Event Reporting System." Acta Psychiatrica Scandinavica 148, no. 1 (2023): 32. https://doi.org/10.1111/acps.13567.

MLA (9th ed.) Citation

BG, Burk, et al. "Antipsychotics and Obsessive-compulsive Disorder/obsessive-compulsive Symptoms: A Pharmacovigilance Study of the FDA Adverse Event Reporting System." Acta Psychiatrica Scandinavica, vol. 148, no. 1, 2023, p. 32, https://doi.org/10.1111/acps.13567.